Is vascular cognitive impairment a useful concept?

被引:6
作者
Korczyn, Amos D. [2 ]
Vakhapova, Veronika [1 ]
机构
[1] Maccabi Hlth Fund, IL-49354 Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sieratzki Chair Neurol, Sch Med, IL-69978 Ramat Aviv, Israel
关键词
Vascular cognitive impairment; Vascular dementia; Mixed dementia; Alzheimer's disease; Therapy; Pathology; TEMPORAL-LOBE ATROPHY; WHITE-MATTER LESIONS; ALZHEIMER-DISEASE; MIXED DEMENTIA; RISK-FACTORS; BRAIN; STROKE; MRI; DECLINE; HYPERINTENSITIES;
D O I
10.1016/j.jns.2010.05.029
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Dementia and milder degrees of cognitive impairment are common in older age. Many causes of dementia have been described, which can be broadly divided into primary neurodegenerative, such as Alzheimer's disease, frontotemporal dementia or dementia with Lewy bodies, and those in which brain changes are secondary to trauma, stroke or infection. This dichotomous separation is conceptually sound. However, the majority of patients with dementia occurring in old age, actually suffer from a combination of neurodegenerative and vascular changes. Attempting to divide the dementia disorder dichotomously into Alzheimer's disease and vascular cognitive impairment may be inappropriate and may mislead the search for important mechanisms and delay the discovery of novel therapeutic targets. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:2 / 4
页数:3
相关论文
共 52 条
  • [1] A clinico-pathological study of heart and brain lesions in vascular dementia
    Andin, U
    Gustafson, L
    Passant, U
    Brun, A
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2005, 19 (04) : 222 - 228
  • [2] [Anonymous], 1994, DIAGN STAT MAN MENT, VFourth, P143
  • [3] Cortical and subcortical diseases: Do true neuropsychological differences exist?
    Arango-Lasprilla, JC
    Rogers, H
    Lengenfelder, J
    DeLuca, J
    Moreno, S
    Lopera, F
    [J]. ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2006, 21 (01) : 29 - 40
  • [4] Medial temporal lobe atrophy on MRI in dementia with Lewy bodies
    Barber, R
    Gholkar, A
    Scheltens, P
    Ballard, C
    McKeith, IG
    O'Brien, JT
    [J]. NEUROLOGY, 1999, 52 (06) : 1153 - 1158
  • [5] BINSWANGER O, 1894, KLIN WOCHENSCHR, V31, P1180
  • [6] Binswanger O., 1894, KLIN WOCHENSCHR, V31, P1137
  • [7] Binswanger O, 1894, KLIN WOCHENSCHR, V31, P1103
  • [8] Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease
    Brickman, Adam M.
    Honig, Lawrence S.
    Scarmeas, Nikolaos
    Tatarina, Oksana
    Sanders, Linda
    Albert, Marilyn S.
    Brandt, Jason
    Blacker, Deborah
    Stern, Yaakov
    [J]. ARCHIVES OF NEUROLOGY, 2008, 65 (09) : 1202 - 1208
  • [9] White matter lesions and hippocampal atrophy in Alzheimer's disease
    de Leeuw, FE
    Barkhof, F
    Scheltens, P
    [J]. NEUROLOGY, 2004, 62 (02) : 310 - 312
  • [10] Treatment of vascular risk factors is associated with slower decline in Alzheimer disease
    Deschaintre, Yan
    Richard, Florence
    Leys, Didier
    Pasquier, Florence
    [J]. NEUROLOGY, 2009, 73 (09) : 674 - 680